Lori Lawley
2021
In 2021, Lori Lawley earned a total compensation of $817.3K as Chief Financial Officer at NewLink Genetics, a 11% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $145,200 |
|---|---|
| Option Awards | $254,588 |
| Salary | $324,438 |
| Stock Awards | $43,577 |
| Other | $49,472 |
| Total | $817,275 |
Lawley received $324.4K in salary, accounting for 40% of the total pay in 2021.
Lawley also received $145.2K in non-equity incentive plan, $254.6K in option awards, $43.6K in stock awards and $49.5K in other compensation.
Rankings
In 2021, Lori Lawley's compensation ranked 9,428th out of 12,415 executives tracked by ExecPay. In other words, Lawley earned more than 24.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,428 out of 12,415 | 24th |
Division Manufacturing | 4,180 out of 5,508 | 24th |
Major group Chemicals And Allied Products | 1,849 out of 2,378 | 22nd |
Industry group Drugs | 1,641 out of 2,099 | 22nd |
Industry Pharmaceutical Preparations | 1,220 out of 1,549 | 21st |
Source: SEC filing on March 23, 2022.
Lawley's colleagues
We found two more compensation records of executives who worked with Lori Lawley at NewLink Genetics in 2021.
News
NewLink Genetics CEO Richard Hawkins' 2023 pay falls 25% to $953K
April 12, 2024
NewLink Genetics CEO Richard Hawkins' 2022 pay slips 6% to $1.3M
March 31, 2023
NewLink Genetics CSO John McKew's 2021 pay rises 15% to $1.4M
March 23, 2022
NewLink Genetics CEO Richard Hawkins' 2020 pay jumps 200% to $2.2M
April 6, 2021